血清淀粉樣P物質(zhì)(SAP)重組蛋白
Recombinant Serum Amyloid P Component (SAP)
APCS; PTX2; Pentaxin-Related; 9.5S Alpha-1-Glycoprotein
- 編號RPB539Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌
- 預(yù)測分子量52.9kDa
- 實(shí)際分子量52kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Leu23~Val223 with N-terminal His and GST Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點(diǎn)6.8
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1008 ¥ 2520 ¥ 5040 ¥ 15120 ¥ 37800
- 欲了解實(shí)際交易價(jià)格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB539Hu01 | 血清淀粉樣P物質(zhì)(SAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB539Hu02 | 血清淀粉樣P物質(zhì)(SAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB539Hu01 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB539Hu02 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB539Hu81 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAB539Hu71 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAB539Hu22 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB539Hu23 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB539Hu24 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB539Hu25 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB539Hu21 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB539Hu | 血清淀粉樣P物質(zhì)(SAP)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCB539Hu | 血清淀粉樣P物質(zhì)(SAP)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMB539Hu | 血清淀粉樣P物質(zhì)(SAP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Journal of Vascular Surgery | Circulation levels of acute phase proteins in patients with Takayasu arteritis [PubMed: 20100644] |
| Journal of Proteome Research | Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes [ACS: pr2005555] |
| Liver International | Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 3-D DIGE [Pubmed: 23944848] |
| Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study [pubmed:28112944] |
| American Journal of Reproductive Immunology | Amniotic fluid pentraxins: Potential early markers for identifying intra‐amniotic inflammatory complications in preterm pre‐labor rupture of membranes [pubmed:29193454] |
| Theranostics | Serum amyloid P component therapeutically attenuates atherosclerosis in mice via its effects on macrophages [Pubmed:29930724] |
| J Med Primatol | Proteopathic lesions in the brain of a super?\aged chimpanzee (Pan troglodytes) [34096618] |
| Clinical and Experimental Immunology | Clinical significance of differential serum-signatures for early prediction of severe dengue among Eastern Indian patients [Pubmed:35348620] |
留言咨詢
